Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University Diego Portales Clínica Vespucio, Santiago, Chile |
---|---|
Information provided by: | University Diego Portales |
ClinicalTrials.gov Identifier: | NCT00696540 |
We will study if small children who become ill with respiratory distress during the RSV epidemic are better relieved with salbutamol nebulizations diluted in hypertonic (3%), instead of normal (0.9%) saline.
Condition | Intervention | Phase |
---|---|---|
Bronchiolitis Respiratory Distress |
Drug: Inhalation of salbutamol diluted in hypertonic saline Drug: Inhalation of salbutamol diluted in normal saline |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Safety and Efficacy of Hypertonic Vrs. Normal Saline as Diluent of Salbutamol to Reduce Respiratory Distress in Outpatients With the Clinical Diagnosis of Bronchiolitis During the RSV Epidemic. |
Estimated Enrollment: | 74 |
Study Start Date: | June 2008 |
Estimated Study Completion Date: | October 2008 |
Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Salbutamol is diluted in hypertonic (3%) saline.
|
Drug: Inhalation of salbutamol diluted in hypertonic saline
The first of 3 nebulizations of 0.5 mg of Salbutamol is diluted in 3.5 ml of hypertonic (3%) saline. The second and the third are diluted in normal (0.9%) saline.
|
2: Active Comparator
Salbutamol is diluted in normal (0.9%) saline.
|
Drug: Inhalation of salbutamol diluted in normal saline
The 3 nebulizations of 0.5 mg of Salbutamol are diluted in 3.5 ml of normal (0.9%) saline.
|
In Santiago, Chile, a near collapse of health services is a notorious feature of every winter when vast numbers of small children line for attention because of respiratory distress caused by a probable RSV infection.
Our study will examine if nebulized salbutamol diluted in hypertonic (3%), instead of normal (0.9%) saline, provides better relief in outpatients.
If hypertonic saline proves safe and effective, the patients could be better managed and the pressure for attention diminished at a low cost, by a simple change in the saline ampule.
Ages Eligible for Study: | 1 Month to 24 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Irmeli Roine, MD, PhD | +56-2-6762916 | irmeli.roine@prof.udp.cl |
Contact: Ricardo Mercado, MD | +56-9-3320792 | rmercado@ssmso.cl |
Chile | |
Clínica Vespucio | Recruiting |
Santiago, Chile, 00300 | |
Contact: Ricardo Mercado, MD +56-2-8206500 rmercado@ssmso.cl | |
Contact: Patricio Olivares, MD +56-2-8206500 patovares@gmail.com |
Principal Investigator: | Irmeli Roine, MD, PhD | University Diego Portales |
Study Director: | Ricardo Mercado, MD | Clinica Vespucio, Santiago, Chile |
Responsible Party: | Facultad de Ciencias de la Salud, Universidad Diego Portales, Santiago. Chile ( Irmeli Roine ) |
Study ID Numbers: | UDP-CT1-08 |
Study First Received: | June 9, 2008 |
Last Updated: | June 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00696540 |
Health Authority: | Chile: Instituto de Salud Publica de Chile |
Bronchiolitis, respiratory distress, hypertonic saline |
Lung Diseases, Obstructive Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases |
Bronchiolitis Albuterol Bronchitis |
Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Bronchial Diseases Adrenergic beta-Agonists Physiological Effects of Drugs Anti-Asthmatic Agents |
Reproductive Control Agents Pharmacologic Actions Adrenergic Agonists Tocolytic Agents Autonomic Agents Therapeutic Uses Peripheral Nervous System Agents Bronchodilator Agents |